Altareit [AREIT] vs Rebirth S.p.A [ALREB] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 16 vital metrics comparison: Altareit wins in 6 metrics, Rebirth S.p.A. wins in 6 metrics, with 1 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Altareit | Rebirth S.p.A. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 29.20 | N/A | N/A |
| Price-to-Book Ratio | 1.57 | 2.25 | Altareit |
| Debt-to-Equity Ratio | 138.95 | 31.31 | Rebirth S.p.A. |
| EV/EBITDA | -245.53 | 144.47 | Rebirth S.p.A. |
| Profit Margin (TTM) | -3.39% | -16.45% | Altareit |
| Operating Margin (TTM) | -4.74% | -2.27% | Rebirth S.p.A. |
| Return on Equity | -7.95% | -4.08% | Rebirth S.p.A. |
| Return on Assets (TTM) | -0.66% | -1.03% | Altareit |
| Free Cash Flow (TTM) | $-84.50M | $-4.54M | Rebirth S.p.A. |
| 1-Year Return | 0.00% | 0.00% | Tie |
| Price-to-Sales Ratio (TTM) | 0.52 | 7.72 | Altareit |
| Enterprise Value | $1.74B | $62.43M | Altareit |
| EV/Revenue Ratio | 0.88 | 9.23 | Altareit |
| Revenue per Share (TTM) | $1,131 | N/A | N/A |
| Earnings per Share (Diluted) | $-38.35 | $0.00 | Rebirth S.p.A. |
| Beta (Stock Volatility) | 0.15 | N/A | N/A |
Altareit vs Rebirth S.p.A. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Altareit | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Rebirth S.p.A. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Altareit | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Rebirth S.p.A. | 0.00% | 0.87% | 0.87% | 0.87% | 0.87% | 0.87% |
Performance & Financial Health Analysis: Altareit vs Rebirth S.p.A.
| Metric | AREIT | ALREB |
|---|---|---|
| Market Information | ||
| Market Cap | €1.03B | €53.19M |
| Market Cap Category | Large cap | Small cap |
| 10 Day Avg. Volume | 1 | 2 |
| 90 Day Avg. Volume | 1 | 1 |
| Last Close | €595.00 | €2.32 |
| 52 Week Range | €496.00 - €595.00 | €2.32 - €2.32 |
| % from 52W High | 0.00% | 0.00% |
| All-Time High | €720.00 (Sep 06, 2021) | €2.32 (May 28, 2025) |
| % from All-Time High | -17.36% | 0.00% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.25% | N/A |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | -0.03% | -0.16% |
| Operating Margin (TTM) | -0.05% | -0.02% |
| Return on Equity (TTM) | -0.08% | -0.04% |
| Debt to Equity (MRQ) | 138.95 | 31.31 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €376.45 | €1.03 |
| Cash per Share (MRQ) | €149.46 | N/A |
| Operating Cash Flow (TTM) | €-84,500,000 | €-1,154,172 |
| Levered Free Cash Flow (TTM) | €-319,275,008 | €-5,495,456 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Altareit vs Rebirth S.p.A.
| Metric | AREIT (Apr 26, 2026) | ALREB (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 29.20 | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| Price to Sales (TTM) | 0.52 | 7.72 |
| Price to Book (MRQ) | 1.57 | 2.25 |
| Market Capitalization | ||
| Market Capitalization | €1.03B | €53.19M |
| Enterprise Value | €1.74B | €62.43M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.88 | 9.23 |
| Enterprise to EBITDA | -245.53 | 144.47 |
| Risk & Other Metrics | ||
| Beta | 0.15 | N/A |
| Book Value per Share (MRQ) | €376.45 | €1.03 |
Financial Statements Comparison: Altareit vs Rebirth S.p.A.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | AREIT (2025) | ALREB (2025) |
|---|---|---|
| Revenue/Sales | 1.82B | 6.77M |
| Cost of Goods Sold | 1.62B | 2.38M |
| COGS % of Revenue | 89.1% | 35.1% |
| Gross Profit | 197.70M | 4.39M |
| Gross Margin | 10.9% | 64.9% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | -37.80M | -712,314 |
| Operating Margin | -2.1% | -10.5% |
| EBITDA | -2.30M | 432,151 |
| EBITDA Margin | -0.1% | 6.4% |
| Pre-Tax Income | -79.50M | -1.19M |
| Pre-Tax Income % of Revenue | -4.4% | -17.6% |
| Income Tax | -22.60M | -26,749 |
| Income Tax % of Revenue | -1.2% | -0.4% |
| Net Income (Profit) | -56.90M | -1.17M |
| Profit Margin | -3.1% | -17.2% |
Balance Sheet & Liquidity Metrics
| Metric | AREIT (2025) | ALREB (2025) |
|---|---|---|
| Cash & Equivalents | 261.60M | 86,775 |
| Total Current Assets | 2.56B | 9.86M |
| Total Current Assets % of Revenue | 140.8% | 145.6% |
| Total Current Liabilities | 2.24B | 6.30M |
| Total Current Liabilities % of Revenue | 123.0% | 93.1% |
| Long-Term Debt | 380.70M | 6.51M |
| Long-Term Debt % of Revenue | 20.9% | 96.2% |
| Total Shareholders Equity | 682.60M | 28.11M |
| Retained Earnings | -67.10M | -3.44M |
| Retained Earnings % of Revenue | -3.7% | -50.9% |
| Property, Plant & Equipment | 156.50M | 30.82M |
Cash Flow Statement Comparison
| Metric | AREIT (2025) | ALREB (2025) |
|---|---|---|
| Operating Cash Flow | 121.90M | -2.06M |
| Operating Cash Flow % of Revenue | 6.7% | -30.4% |
| Capital Expenditures | N/A | -3.15M |
| Free Cash Flow | -84.50M | -4.54M |
| FCF Margin | -4.6% | -67.1% |
| Debt Repayment | -568.20M | N/A |
| Common Stock Repurchase | N/A | 0 |
Short Interest & Institutional Ownership Analysis
| Metric | AREIT | ALREB |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 1.75M | 22.78M |
| Float Shares | 4,306 | N/A |
| % Held by Insiders | 99.85% | 107.35% |
| % Held by Institutions | 0.00% | 0.00% |
| % Held by Public | 0.15% | -7.35% |
Dividend Analysis & Yield Comparison: Altareit vs Rebirth S.p.A.
| Metric | AREIT | ALREB |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |